Skip to main content
. 2017 Jun 8;14(2):1215–1222. doi: 10.3892/ol.2017.6351

Table I.

Abnormal expression and target genes of miR-139-5p in different types of cancers.

Cancer type miR-139-5p expression Target gene (Refs.)
Head and neck/oral cancer Downregulated Unknown (6,7)
Breast cancer Downregulated TOP2a, H2AFV, HRAS, RAF, NFKB1, PIK3CA, RHOT1 (20,35,69)
Gastric cancer Downregulated CXCR4, c-Jun (79)
Endometrial serous adenocarcinoma Downregulated Unknown (16)
Colorectal cancer Downregulated IGF-1R, ROCK2, RAP1B, TSPAN5, FOXO1A, TNFα, Fas, AMFR, NOTCH1, ETS1 (38,48,50,52,53,56)
Bladder cancer Downregulated Unknown (18)
Hepatocellular carcinoma Downregulated EZH2, ROCK2, ZEB1/2, c-Fos (5759,6365)
Ovarian cancer Downregulated TOP2a, RACGAP1, DNAH9, E2F3 (20)
Esophageal squamous cell carcinoma Downregulated NR5A2 (21,22)
Thyroid carcinoma Downregulated Unknown (23)
Glioblastoma Downregulated Mcl-1 (24)
Basal cell carcinoma Downregulated Unknown (25)
Renal cell carcinoma Downregulated Unknown (26)
Lung squamous cell carcinoma Downregulated CXCR4 (27)
Non-small cell lung cancer Downregulated IGF-1R (28)
Pancreatic cancer Upregulated Unknown (29)
Granulosa cell tumor Upregulated PGRMC1 (32)

miR, microRNA.